This commentary reports on a "must-read" study comparing wound instillation methods for post-cesarean analgesia.

The Safe Use Initiative is taking aim at adverse drug events and seeks input on safety issues encountered by frontline clinicians.

Frank Veith, MD, believes that the initiative to separate physicians from industry is excessive and can lead to harm for patients. What do you think?

Dr. John Marshall asks: If health insurance is a choice that individuals can opt not to have, who pays for the care of the 40 million people in the United States who have no healthcare insurance?

Many people think that privacy of medical treatment should not apply to everyone. An ethics expert tells why privacy protects all of society.

Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety.

Robert Resnik, MD, gives a useful overview of placenta accreta and warns obstetricians that they should be aware of this serious complication given the dramatic increase in cesarean sections.

Thomas Ahlborn, MD, responds to the State of the Union message and expresses his concern and offers alternative solutions for healthcare issues that President Obama did not address.

David Feifel, MD, talks about 2 old agents that are promising for difficult-to-treat depression: ketamine and scopolamine.

Robert Morrow, MD, stressed what Obama left out and is encouraged by the future implementation of many positive changes, particularly for primary care.